CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-02 | OYLER JOHN Chief Executive Officer | Sale | −5,565 | $332.05 | $1.8M | 320 |
| 2021-09-02 | OYLER JOHN Chief Executive Officer | Sale | −320 | $332.75 | $106K | 0 |
| 2021-09-02 | Huang Jane CMO, Hematology | Sale | −545 | $327.18 | $178K | 0 |
| 2021-09-01 | OYLER JOHN Chief Executive Officer | Sale | −127,158 | $24.34 | $3.1M | 3,567,562 |
| 2021-09-01 | OYLER JOHN Chief Executive Officer | Sale | −400 | $24.71 | $10K | 2,917,162 |
| 2021-09-01 | OYLER JOHN Chief Executive Officer | Sale | −10,424 | $324.41 | $3.4M | 15,077 |
| 2021-09-01 | OYLER JOHN Chief Executive Officer | Sale | −4,600 | $325.55 | $1.5M | 10,477 |
| 2021-09-01 | OYLER JOHN Chief Executive Officer | Sale | −3,772 | $326.48 | $1.2M | 6,705 |
| 2021-09-01 | OYLER JOHN Chief Executive Officer | Sale | −6,705 | $327.50 | $2.2M | 0 |
| 2021-09-01 | Huang Jane CMO, Hematology | Grant or award | +7,124 | 312,948 | ||
| 2021-09-01 | Huang Jane CMO, Hematology | Sale | −542 | $310.53 | $168K | 0 |
| 2021-09-01 | Huang Jane CMO, Hematology | Grant or award | +545 | 545 | ||
| 2021-08-31 | OYLER JOHN Chief Executive Officer | Sale | −76,800 | $23.67 | $1.8M | 3,694,720 |
| 2021-08-31 | OYLER JOHN Chief Executive Officer | Sale | −700 | $299.74 | $210K | 33,581 |
| 2021-08-31 | OYLER JOHN Chief Executive Officer | Sale | −5,242 | $300.68 | $1.6M | 28,339 |
| 2021-08-31 | OYLER JOHN Chief Executive Officer | Sale | −4,856 | $301.68 | $1.5M | 23,483 |
| 2021-08-31 | OYLER JOHN Chief Executive Officer | Sale | −4,624 | $302.50 | $1.4M | 18,859 |
| 2021-08-31 | OYLER JOHN Chief Executive Officer | Sale | −4,858 | $303.65 | $1.5M | 14,001 |
| 2021-08-31 | OYLER JOHN Chief Executive Officer | Sale | −3,300 | $304.69 | $1.0M | 10,701 |
| 2021-08-31 | OYLER JOHN Chief Executive Officer | Sale | −3,404 | $305.69 | $1.0M | 7,297 |
Page 60 of 99 · 1,972 trades